To examine health outcomes and quality of life in cancer survivors across all diagnoses, all ages, and across entire trajectory of disease (diagnosis to end-of-life)

To understand causes of disparities in cancer outcome

To understand the molecular underpinnings/pathogenesis of cancer outcomes

To develop risk prediction models to identify those at highest risk of morbidity/mortality

To develop, implement and evaluate interventions to reduce cancer-related morbidity/mortality, and improve quality of life

To create infrastructure to standardize the care of cancer survivors

To examine economic burden (societal and personal) of cancer care across the entire trajectory of disease